L&C BIO Co.,LTD

₩23,750As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:290650Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR 29.82%
Div yield 0.11%
ROE (45.32%)
Medical Devices
Beta (5Y) 1.49
PE TTM —
TSR TTM (6.90%)
Mkt cap ₩1.281T
ROIC 6.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩29,819
25.55%
151.13%
Hold 5|0|9|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
254.19
262.32
250.13
239.49
15.10%
6.34%
1.98%
(6.57%)
Revenue₩B
74.64
78.24
80.48
79.52
5.85%
13.42%
11.31%
4.00%
Peers (US$944.5M)
Cap (US$)
PE
1.243B
12.32x
1.041B
15.52x
578.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.540
0.477
0.296
EBIT/Intx
0.227
0.100
0.115
Own earn%
2.12
(25.97)
(28.35)
Sh yield%
38.97
15.79
18.33
Owners
Insiders/Inst%
10.09
76.90
Short interest%
3.78
SBC / revenue%
4.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
0–4
$1 testx
0.0
Incr. ROIC%
20